Ozempic Found to Reduce Symptoms of Peripheral Artery Disease in Diabetics
A new study published in The Lancet reveals that semaglutide, a medication commonly known as Ozempic, has been found to reduce the symptoms of peripheral artery disease (PAD) in people with diabetes. PAD is a condition characterized by narrowed arteries that restrict blood flow to the arms and legs, leading to complications such as tingling, … Read more